Partner Article

Conservative MP Adam Afriyie MP joins leading healthcare & wellness company Elite Growth as Board Chairman

Windsor MP, Adam Afriyie has recently been appointed as Chairman for leading healthcare company Elite Growth, to help further their mission to improve lives via cannabinoid treatments, plant-based medicines and wellness products.

Adam Afriyie MP and Chair of Elite Growth said of his appointment: “I’m thrilled to be joining as Chair to work with Elite’s outstanding management team and to assist in delivering market leading products through cutting edge research and development, which will bring real change on a clinical level with the ability to improve many lives for the better. Above all we will be looking to fill the deficit in robust research for product claims around cannabinoids and other plant-based ingredients to ensure that patients and consumers can be confident in these products. This is a tremendous opportunity to be able to contribute to the transformation of healthcare, ensuring safe and efficacious products are universally accessible and beneficial.”

Elite Growth is a fast-growing group of companies with a strong portfolio of assets and expertise across clinical trial development, medical wholesale, patient advocacy and consumer retail wellbeing products. With ambitious growth plans for product sales, strategic acquisitions and licensing underpinned by key partnership agreements, the company is going from strength to strength.

Robin Emerson, co-founder and COO of Elite Growth said: “We’re delighted Adam has accepted this position to provide the benefit of his business expertise, leadership, and knowledge of the investment landscape. Elite Growth’s vision is a world in which patients and consumers have access to a certified, safe, and consistent supply of medical and retail cannabinoid products, and Adam’s experience and expertise will only accelerate our progress.”

Liam McGreevy, co-founder and CEO of Elite Growth said: “Adam Afriyie’s appointment shows our continued commitment to driving market growth with a focus on delivering for patients, consumers, partners and investors, with results driven by the science. With Adam’s wealth of business experience and passion for innovation, he adds significant strength to our Board and management team, and his appointment is a milestone for our sector in the UK, as well as for Elite Growth. We look forward to further expanding our business as we play an ever-more significant role in shaping the UK’s medical and wellness cannabinoid market.”

This was posted in Bdaily's Members' News section by Sandra Griffiths .